AHA: Impact of Valsartan Recall Examined for Ontario, Canada Physician’s Briefing Staff Nov 18, 2019 Physician's Briefing
FDA: Risk From Tainted Blood Pressure Drugs Very Low Physician’s Briefing Staff Aug 29, 2019 Physician's Briefing
FDA Approves New Generic Valsartan to Ease Shortage Physician’s Briefing Staff Mar 13, 2019 Physician's Briefing
Teva Recalls Two Blood Pressure Medications Physician’s Briefing Staff Nov 30, 2018 Physician's Briefing
FDA Finds Another Carcinogen in Certain Valsartan Heart Meds Physician’s Briefing Staff Sep 14, 2018 Physician's Briefing
No Apparent Short-Term Cancer Risk From Recalled Valsartan Physician’s Briefing Staff 13 Sep, 2018 Physician's Briefing
FDA Recalls Drugs Containing Active Ingredient Valsartan Physician’s Briefing Staff 19 Jul, 2018 Physician's Briefing
